Key facts
- Crainio’s last known valuation is $3.4M (Aug 2025).
- It has raised $950K.
- Notable investors include Innovate UK, NLC Health Ventures, National Institute for Health Research Invention for Innovation, Stepping Stones, University of London.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Crainio
- ·The full record, as it builds
Funding rounds
No funding rounds for Crainio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Crainio
Developer of a non-invasive intracranial pressure measurement device designed to provide continuous estimates of brain pressure for traumatic brain injury diagnosis. The company offers a low-power infrared light sensor combined with machine learning algorithms, enabling clinicians to monitor patients without invasive procedures and support more accurate diagnosis and treatment.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 6
- Website
- crainiotech.co.uk/
- Ownership
- Privately Held (backing)
Crainio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Crainio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Crainio in its N-PORT filings yet. We sweep new filings monthly.